Lenalidomide and Low Dose Dexamethasone Versus Bortezomib, Lenalidomide and Low Dose Dexamethasone for Induction, in Patients With Previously Untreated Multiple Myeloma

NCT01530594 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

440

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Lenalidomide/Low dose Dex
DRUG: Bortezomib/Lenalidomide/ Low dose Dex
DRUG: Lenalidomide

Sponsor

King Faisal Specialist Hospital & Research Center